MaxRets Ventures Appoints Non-Executive Director

MaxRets Ventures PLC,(LSE:MAX),has announced the appointment of Luca Zanni as a non-executive director. Zanni, aged 44, is recognized for his extensiv...

Panmure Says - Scancell Well-Positioned to Secure Funding

Broker Panmure Liberum has reiterated its favorable rating on Scancell Holdings PLC (LSE:SCLP) shares, maintaining a target price of 23.3p in light of...

Scancell Partners with ParmaJet for Needle-Free Cancer Vaccine Deliv...

Scancell Holdings PLC,(LSE:SCLP),has entered into a strategic partnership with PharmaJet to provide the Stratis intramuscular (IM) needle-free injecti...

Ananda Raises £2.2M Total, with Additional £80K from Retail Offer

Ananda Developments Plc (AQSE: ANA) has announced the successful raising of £2.225 million through a combination of financing efforts. The total amoun...

AstraZeneca Drops After Downgrade Following Cancer Drug Update

AstraZeneca,(LSE:AZN),experienced a decline of £4 billion in its market value following a downgrade from Deutsche Bank, which has revised its recommen...

Proteome Sciences Slips as Losses Mount and CEO Steps Down

Proteome Sciences PLC,(LSE:PRM),experienced a significant drop of over 17% in its share value on the back of a recent announcement detailing increased...

GSK's Cancer Drugs Fast-Tracked for Approval in China

GSK PLC,(LSE:GSK),has announced that its blood cancer medication, Blenrep (belantamab mafodotin), has been granted Breakthrough Therapy Designation (B...

Premier African to Announce Zulu Plant Restart Date Following Lab Te...

Premier African Minerals Ltd,(LSE:PREM),has received an update from its flotation plant supplier, Enprotec, indicating that no major fundamental chang...

Futura Medical Consensus Significantly Increases

Analysts tracking Futura Medical PLC,(LSE:FUM),have revised and notably increased their revenue forecasts following the company's better-than-anticipa...

Haleon Announces Pricing for £1bn Bond Offering

Haleon PLC,(LSE:HLN),has announced the pricing details for a significant bond offering, expected to raise nearly £1 billion through its subsidiary. Th...

GSK Achieves Success in mRNA Flu Vaccine Trial

GSK PLC,(LSE:GSK),has reported promising results for its mRNA-based seasonal flu vaccine. The company has advanced this vaccine to phase III trials fo...

Renishaw (LSE:RSW): Steady growth in analytical instruments and medi...

Renishaw plc (LSE:RSW) has reported its financial results for the year ended 30 June 2024, delivering record revenue of £691.3 million, slightly up fr...

Celadon Pharmaceuticals Shares Fall 20% After Discounted Fundraiser

Shares of Celadon Pharmaceuticals PLC,(LSE: CEL),fell by 20% following the announcement of a £1.05 million equity fundraising round, which involved is...

ANGLE Technology Establishes New Benchmark in Cancer Diagnostics

ANGLE PLC,(LSE:AGL),has received high praise from German investment bank Berenberg, which has reaffirmed its 'buy' recommendation and 70p price target...

Arecor Receives Positive Review, Price Target Maintained

Panmure Liberum has reaffirmed its positive rating and ambitious price target for shares in Arecor Therapeutics PLC,(LSE:AREC),following the company’s...

Futura Medical: Investment Bank Affirms Performance Matches Claims

"Doing what it says on the tube" was the headline from a Panmure Liberum report following Futura Medical PLC's,(LSE:FUM),interim results.,The report h...

Arecor Therapeutics Presents Promising Data at Madrid Conference

Arecor Therapeutics PLC,(LSE:AREC),will present positive Phase I trial results for its ultra-concentrated, ultra-rapid-acting insulin, AT278, at the E...

AstraZeneca Shares Slide After Lung Cancer Trial Update

The share price of AstraZeneca,(LSE: AZN),experienced a significant decline on Tuesday following disappointing updates from the company's latest lung...

CVS Group Shares Rise Despite Intrinsic Value Gap

CVS Group plc, operating within the,healthcare sector,, has recently experienced a notable increase in its share price, rising over 10% on the AIM mar...

Futura Posts Early Maiden Profit, Revenue and Earnings to Surge

Futura Medical PLC,(LSE:FUM),has announced a significant milestone in its financial performance for the first half of 2024, marking its first profit o...